Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes
Wednesday 12 March 2025, 12:55 AM
14 minutes to Read
CLASStime: Adult attention deficit hyperactivity disorder
Monday 1 July 2024, 12:40 AM
[Image: Fraser Williamson]
Adult attention deficit hyperactivity disorder is a fairly new and exciting area of research in psychiatry. In this article, Sidhesh Phaldessai examines our increasing understanding of the symptom presentation and management of this neurodevelopmental disorder in adults
Our suite of CLASS activities provides meaningful independent and peer group learning that you can put into action, while helping you complete your an
Kia ora and welcome to Pharmacy Today Kaitiaki Rongoā O Te Wā
Not a subscriber? Unlock this article by subscribing here.
References
1. Volkow ND, Swanson JM. Clinical practice: Adult attention deficit-hyperactivity disorder. N Engl J Med 2013;369(20):1935–44.
2. Fayyad J, De Graaf R, Kessler R, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007;190:402–09.
3. Biederman J, Faraone SV. The effects of attention-deficit/hyperactivity disorder on employment and household income. MedGenMed 2006;8(3):12.
4. Ronald A, Simonoff E, Kuntsi J, et al. Evidence for overlapping genetic influences on autistic and ADHD behaviours in a community twin sample. J Child Psychol Psychiatry 2008;49(5):535–42.
5. National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: diagnosis and management. NICE guideline NG87, 13 September 2019.
Class
Hosted Content 2
Chemist Warehouse is sponsoring the Young Pharmacist of the Year Award in the 2025 New Zealand Primary Healthcare Awards | He Tohu Mauri Ora. The Chemist Warehouse leadership team explains what it means to be a Stellar Supporter
Thursday 20 February 2025, 08:03 AM
1 minute to Read
Latest issue
